PMID- 32845475 OWN - NLM STAT- MEDLINE DCOM- 20211220 LR - 20211220 IS - 1522-1709 (Electronic) IS - 1520-9512 (Linking) VI - 25 IP - 2 DP - 2021 Jun TI - Effects of endobronchial coils for endoscopic lung volume reduction on sleep in COPD patients with advanced pulmonary emphysema. PG - 727-735 LID - 10.1007/s11325-020-02176-0 [doi] AB - PURPOSE: Treatment of advanced pulmonary emphysema with endobronchial coils can improve clinical outcomes like quality of life (QOL). Yet, patients with chronic obstructive pulmonary disease (COPD) are also known to suffer from reduced sleep quality. The effect of coil therapy on sleep has not yet been investigated. The primary aim of this study was to investigate sleep efficiency before and after coil treatment. Secondly, we investigated the effects on nocturnal breathing pattern, QOL, and physical activity. METHODS: Polysomnography (PSG) testing was performed before (T0), 6 month after (T3), and 12 months after (T4) treatment with endobronchial coils. Further examinations included QOL by St George's Respiratory Questionnaire (SGRQ) and COPD assessment test (CAT), and physical activity using an accelerometer for 1 week after each visit. RESULTS: Of 21 patients, 14 completed the study: 6 women; mean age 58.0 +/- 4.9 years; BMI 22.6 +/- 4.6 kg/m(2); FEV(1) 28.6 +/- 7.1% predicted; residual volume (RV) 278.2 +/- 49.4% predicted. Sleep efficiency did not vary between baseline and follow-up examinations (T0 69.0 +/- 15.8%; T3 70.9 +/- 16.0%; T4 66.8 +/- 18.9%). Non-REM respiratory rate decreased compared to baseline (T0 19.4 +/- 3.9/min; T3 17.8 +/- 3.5/min; T4 17.1 +/- 3.1/min (p = 0.041; p = 0.030) and QOL improved meeting the minimal clinically important difference (MCID) (SGRQ, T3 -12.8 units; T4 -7.1 units; CAT: T3 -5.6 units; T4 -3.4 units). No increase in physical activity was recorded (light activity T0 31.9 +/- 9.9; T3 30.8 +/- 16.9; T4 26.3 +/- 10.6 h/week). CONCLUSIONS: Treatment with endobronchial coils did not influence objectively measured sleep quality or physical activity, but reduced nocturnal breathing frequency and improved QOL in severe emphysema patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02399514, First Posted: March 26, 2015. FAU - Franke, Karl-Josef AU - Franke KJ AD - Markische Kliniken GmbH, Klinikum Ludenscheid, Ludenscheid, Germany. AD - Witten-Herdecke University, Witten, Germany. FAU - Domanski, Ulrike AU - Domanski U AD - VAMED Klinik Hagen-Ambrock GmbH, Hagen, Germany. FAU - Schroder, Maik AU - Schroder M AUID- ORCID: 0000-0002-1794-2710 AD - Kliniken Essen-Mitte, Essen, Germany. m.schroeder@kem-med.com. FAU - Nilius, Georg AU - Nilius G AD - Kliniken Essen-Mitte, Essen, Germany. AD - Witten-Herdecke University, Witten, Germany. LA - eng SI - ClinicalTrials.gov/NCT02399514 PT - Journal Article DEP - 20200826 PL - Germany TA - Sleep Breath JT - Sleep & breathing = Schlaf & Atmung JID - 9804161 SB - IM MH - Female MH - Humans MH - Male MH - Middle Aged MH - Pneumonectomy/*methods MH - Pulmonary Disease, Chronic Obstructive/*physiopathology MH - Pulmonary Emphysema/physiopathology/*surgery MH - Quality of Life MH - Sleep/*physiology MH - Sleep Quality MH - Surveys and Questionnaires MH - Treatment Outcome OTO - NOTNLM OT - Endobronchial coils OT - Lung volume reduction OT - PSG OT - Physical activity OT - Quality of life OT - Sleep EDAT- 2020/08/28 06:00 MHDA- 2021/12/21 06:00 CRDT- 2020/08/27 06:00 PHST- 2020/05/08 00:00 [received] PHST- 2020/08/19 00:00 [accepted] PHST- 2020/08/05 00:00 [revised] PHST- 2020/08/28 06:00 [pubmed] PHST- 2021/12/21 06:00 [medline] PHST- 2020/08/27 06:00 [entrez] AID - 10.1007/s11325-020-02176-0 [pii] AID - 10.1007/s11325-020-02176-0 [doi] PST - ppublish SO - Sleep Breath. 2021 Jun;25(2):727-735. doi: 10.1007/s11325-020-02176-0. Epub 2020 Aug 26.